Click here to get full coverage on ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - ChartMill

ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY)  ChartMill

ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - ChartMill

Click here to get full coverage on Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 49.88% Potential Upside for Biotech Investors - DirectorsTalk Interviews

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 49.88% Potential Upside for Biotech Investors  DirectorsTalk Interviews

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 49.88% Potential Upside for Biotech Investors - DirectorsTalk Interviews

Click here to get full coverage on Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake - simplywall.st

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake  simplywall.st

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake - simplywall.st

Click here to get full coverage on ALNY (ALNY) director granted 671 RSUs and 1,441 options at $298.48 - Stock Titan

ALNY (ALNY) director granted 671 RSUs and 1,441 options at $298.48  Stock Titan

ALNY (ALNY) director granted 671 RSUs and 1,441 options at $298.48 - Stock Titan

Click here to get full coverage on Discipline and Rules-Based Execution in ALNY Response - Stock Traders Daily

Discipline and Rules-Based Execution in ALNY Response  Stock Traders Daily

Discipline and Rules-Based Execution in ALNY Response - Stock Traders Daily

Click here to get full coverage on ALNY: All proposals passed; robust revenue growth and ambitious 2030 innovation goals outlined - TradingView

ALNY: All proposals passed; robust revenue growth and ambitious 2030 innovation goals outlined  TradingView

ALNY: All proposals passed; robust revenue growth and ambitious 2030 innovation goals outlined - TradingView

Click here to get full coverage on ALNY Initiated Coverage by Citigroup -- Price Target Set at $380 - GuruFocus

ALNY Initiated Coverage by Citigroup -- Price Target Set at $380  GuruFocus

ALNY Initiated Coverage by Citigroup -- Price Target Set at $380 - GuruFocus

Click here to get full coverage on Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY) - Yahoo Finance

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY)  Yahoo Finance

Morgan Stanley Increases Price Goal on Alnylam Pharmaceuticals, Inc. (ALNY) - Yahoo Finance

Click here to get full coverage on Ionis, Alnylam, BioMarin are new Buys at Citi (ALNY:NASDAQ) - Seeking Alpha

Ionis, Alnylam, BioMarin are new Buys at Citi (ALNY:NASDAQ)  Seeking Alpha

Ionis, Alnylam, BioMarin are new Buys at Citi (ALNY:NASDAQ) - Seeking Alpha

Click here to get full coverage on Alnylam (NASDAQ: ALNY) awards RSUs and options to board director - Stock Titan

Alnylam (NASDAQ: ALNY) awards RSUs and options to board director  Stock Titan

Alnylam (NASDAQ: ALNY) awards RSUs and options to board director - Stock Titan

Click here to get full coverage on How Investors Are Reacting To Alnylam Pharmaceuticals (ALNY) New HELIOS-B Vutrisiran Data And Real-World Study - Yahoo Finance

How Investors Are Reacting To Alnylam Pharmaceuticals (ALNY) New HELIOS-B Vutrisiran Data And Real-World Study  Yahoo Finance

How Investors Are Reacting To Alnylam Pharmaceuticals (ALNY) New HELIOS-B Vutrisiran Data And Real-World Study - Yahoo Finance

Click here to get full coverage on ALNY (ALNY) director Dennis Ausiello granted RSUs and stock options awards - Stock Titan

ALNY (ALNY) director Dennis Ausiello granted RSUs and stock options awards  Stock Titan

ALNY (ALNY) director Dennis Ausiello granted RSUs and stock options awards - Stock Titan

Click here to get full coverage on Is It Time To Reconsider Alnylam Pharmaceuticals (ALNY) After Recent RNAi Progress And Volatile Price Moves - simplywall.st

Is It Time To Reconsider Alnylam Pharmaceuticals (ALNY) After Recent RNAi Progress And Volatile Price Moves  simplywall.st

Is It Time To Reconsider Alnylam Pharmaceuticals (ALNY) After Recent RNAi Progress And Volatile Price Moves - simplywall.st

Click here to get full coverage on Alnylam (ALNY) director gets new RSUs, options and reports trust holdings - Stock Titan

Alnylam (ALNY) director gets new RSUs, options and reports trust holdings  Stock Titan

Alnylam (ALNY) director gets new RSUs, options and reports trust holdings - Stock Titan

Click here to get full coverage on Alnylam (ALNY) director granted RSUs and stock options in new equity awards - Stock Titan

Alnylam (ALNY) director granted RSUs and stock options in new equity awards  Stock Titan

Alnylam (ALNY) director granted RSUs and stock options in new equity awards - Stock Titan

Click here to get full coverage on Director at Alnylam (NASDAQ: ALNY) receives RSUs and options - Stock Titan

Director at Alnylam (NASDAQ: ALNY) receives RSUs and options  Stock Titan

Director at Alnylam (NASDAQ: ALNY) receives RSUs and options - Stock Titan

Click here to get full coverage on Director Peter Kellogg granted RSUs and stock options at Alnylam (NASDAQ: ALNY) - Stock Titan

Director Peter Kellogg granted RSUs and stock options at Alnylam (NASDAQ: ALNY)  Stock Titan

Director Peter Kellogg granted RSUs and stock options at Alnylam (NASDAQ: ALNY) - Stock Titan

Click here to get full coverage on Director at Alnylam (NASDAQ: ALNY) granted RSUs and stock options - Stock Titan

Director at Alnylam (NASDAQ: ALNY) granted RSUs and stock options  Stock Titan

Director at Alnylam (NASDAQ: ALNY) granted RSUs and stock options - Stock Titan

Click here to get full coverage on Alnylam (ALNY) director Olivier Brandicourt receives new RSU and option grants - Stock Titan

Alnylam (ALNY) director Olivier Brandicourt receives new RSU and option grants  Stock Titan

Alnylam (ALNY) director Olivier Brandicourt receives new RSU and option grants - Stock Titan

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Advances Diabetes Drug Into Phase 2 Trial - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock? - Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock?  Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock? - Yahoo Finance

Click here to get full coverage on ALNYLAM PHARMACEUTICALS ($ALNY) Releases Q1 2026 Earnings - Quiver Quantitative

ALNYLAM PHARMACEUTICALS ($ALNY) Releases Q1 2026 Earnings  Quiver Quantitative

ALNYLAM PHARMACEUTICALS ($ALNY) Releases Q1 2026 Earnings - Quiver Quantitative

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal - Yahoo Finance

Click here to get full coverage on How HELIOS-B Phase 3 Vutrisiran Data and Real-World Evidence Expansion Will Impact Alnylam (ALNY) Investors - simplywall.st

How HELIOS-B Phase 3 Vutrisiran Data and Real-World Evidence Expansion Will Impact Alnylam (ALNY) Investors  simplywall.st

How HELIOS-B Phase 3 Vutrisiran Data and Real-World Evidence Expansion Will Impact Alnylam (ALNY) Investors - simplywall.st

Click here to get full coverage on Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? - Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?  Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? - Yahoo Finance

Click here to get full coverage on Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? - Yahoo Finance

Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet?  Yahoo Finance

Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? - Yahoo Finance

Click here to get full coverage on Is Alnylam (ALNY) One of the Best Aggressive Growth Stocks to Buy? - Yahoo Finance

Is Alnylam (ALNY) One of the Best Aggressive Growth Stocks to Buy?  Yahoo Finance

Is Alnylam (ALNY) One of the Best Aggressive Growth Stocks to Buy? - Yahoo Finance

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness - Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness  Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness - Yahoo Finance

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple - Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple  Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy?  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Click here to get full coverage on Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models - Yahoo Finance

Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models  Yahoo Finance

Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models - Yahoo Finance

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Unveiling Its Alnylam 2030 Growth Plan - Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Unveiling Its Alnylam 2030 Growth Plan  Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Unveiling Its Alnylam 2030 Growth Plan - Yahoo Finance

Click here to get full coverage on Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth - Yahoo Finance

Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth  Yahoo Finance

Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) slides 4% as valuation concerns linger after recent analyst reset | ALNY Stock News - Quiver Quantitative

Alnylam (ALNY) slides 4% as valuation concerns linger after recent analyst reset | ALNY Stock News  Quiver Quantitative

Alnylam (ALNY) slides 4% as valuation concerns linger after recent analyst reset | ALNY Stock News - Quiver Quantitative

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation As HELIOS B Data And TTR Guidance Reassure Investors - simplywall.st

A Look At Alnylam Pharmaceuticals (ALNY) Valuation As HELIOS B Data And TTR Guidance Reassure Investors  simplywall.st

A Look At Alnylam Pharmaceuticals (ALNY) Valuation As HELIOS B Data And TTR Guidance Reassure Investors - simplywall.st

Click here to get full coverage on Citigroup initiates coverage of Alnylam Pharmaceuticals (ALNY) with buy recommendation - MSN

Citigroup initiates coverage of Alnylam Pharmaceuticals (ALNY) with buy recommendation  MSN

Citigroup initiates coverage of Alnylam Pharmaceuticals (ALNY) with buy recommendation - MSN

Click here to get full coverage on Alnylam (NASDAQ: ALNY) director exercises 11,250 stock options at $70.20 - Stock Titan

Alnylam (NASDAQ: ALNY) director exercises 11,250 stock options at $70.20  Stock Titan

Alnylam (NASDAQ: ALNY) director exercises 11,250 stock options at $70.20 - Stock Titan

Click here to get full coverage on Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock - Yahoo Finance

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock  Yahoo Finance

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News - Quiver Quantitative

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News  Quiver Quantitative

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News - Quiver Quantitative

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue Estimates  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly - Yahoo Finance

Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly  Yahoo Finance

Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly - Yahoo Finance

Click here to get full coverage on Capital World Investors holds 10.9M Alnylam shares (NASDAQ: ALNY) - Stock Titan

Capital World Investors holds 10.9M Alnylam shares (NASDAQ: ALNY)  Stock Titan

Capital World Investors holds 10.9M Alnylam shares (NASDAQ: ALNY) - Stock Titan

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now - Yahoo Finance

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now  Yahoo Finance

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now - Yahoo Finance

Click here to get full coverage on Capital Research holds 9.47M shares of Alnylam (NASDAQ: ALNY) in 13G/A - Stock Titan

Capital Research holds 9.47M shares of Alnylam (NASDAQ: ALNY) in 13G/A  Stock Titan

Capital Research holds 9.47M shares of Alnylam (NASDAQ: ALNY) in 13G/A - Stock Titan

Click here to get full coverage on Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback - Yahoo Finance

Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback  Yahoo Finance

Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies - Yahoo Finance

Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies  Yahoo Finance

Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies - Yahoo Finance

Click here to get full coverage on Assessing Alnylam Pharmaceuticals’ (ALNY) Valuation After Its Inclusion in the Nasdaq 100 Index - Yahoo Finance

Assessing Alnylam Pharmaceuticals’ (ALNY) Valuation After Its Inclusion in the Nasdaq 100 Index  Yahoo Finance

Assessing Alnylam Pharmaceuticals’ (ALNY) Valuation After Its Inclusion in the Nasdaq 100 Index - Yahoo Finance

Click here to get full coverage on Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Yahoo Finance

Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth  Yahoo Finance

Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Yahoo Finance

Click here to get full coverage on ALNY Technical Analysis & Stock Price Forecast - Intellectia AI

ALNY Technical Analysis & Stock Price Forecast  Intellectia AI

ALNY Technical Analysis & Stock Price Forecast - Intellectia AI

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025 - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025 - Yahoo Finance

Click here to get full coverage on ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down - Yahoo Finance

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down  Yahoo Finance

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down - Yahoo Finance

Click here to get full coverage on Truist Lowers PT on Alnylam Pharmaceuticals (ALNY) to $505 From $515 - Yahoo Finance

Truist Lowers PT on Alnylam Pharmaceuticals (ALNY) to $505 From $515  Yahoo Finance

Truist Lowers PT on Alnylam Pharmaceuticals (ALNY) to $505 From $515 - Yahoo Finance

Click here to get full coverage on Blood pressure, safety, sex analysis: Alnylam adds new ATTR-CM data - Stock Titan

Blood pressure, safety, sex analysis: Alnylam adds new ATTR-CM data  Stock Titan

Blood pressure, safety, sex analysis: Alnylam adds new ATTR-CM data - Stock Titan

Click here to get full coverage on Alnylam (ALNY) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Alnylam (ALNY) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates  Yahoo Finance

Alnylam (ALNY) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Click here to get full coverage on Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News - Quiver Quantitative

Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News  Quiver Quantitative

Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News - Quiver Quantitative

Click here to get full coverage on Heart drug vutrisiran tied to fewer deaths in ATTR-CM patients - Stock Titan

Heart drug vutrisiran tied to fewer deaths in ATTR-CM patients  Stock Titan

Heart drug vutrisiran tied to fewer deaths in ATTR-CM patients - Stock Titan

Click here to get full coverage on Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? - Yahoo Finance

Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential?  Yahoo Finance

Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? - Yahoo Finance

Click here to get full coverage on Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3 - Yahoo Finance

Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3  Yahoo Finance

Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3 - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Earnings Turn To Profitability Challenges Premium P/E Narrative - simplywall.st

Alnylam Pharmaceuticals (ALNY) Earnings Turn To Profitability Challenges Premium P/E Narrative  simplywall.st

Alnylam Pharmaceuticals (ALNY) Earnings Turn To Profitability Challenges Premium P/E Narrative - simplywall.st

Click here to get full coverage on Alnylam backs AI screening and a 10-site effort for missed heart disease - Stock Titan

Alnylam backs AI screening and a 10-site effort for missed heart disease  Stock Titan

Alnylam backs AI screening and a 10-site effort for missed heart disease - Stock Titan

Click here to get full coverage on How Alnylam’s Swing to Quarterly Profitability Could Reshape the Outlook for Alnylam Pharmaceuticals (ALNY) Investors - simplywall.st

How Alnylam’s Swing to Quarterly Profitability Could Reshape the Outlook for Alnylam Pharmaceuticals (ALNY) Investors  simplywall.st

How Alnylam’s Swing to Quarterly Profitability Could Reshape the Outlook for Alnylam Pharmaceuticals (ALNY) Investors - simplywall.st

Click here to get full coverage on FMR LLC amends Schedule 13G to show 14.64M ALNY shares (NASDAQ: ALNY) - Stock Titan

FMR LLC amends Schedule 13G to show 14.64M ALNY shares (NASDAQ: ALNY)  Stock Titan

ALNY

Price Chart

Key Statistics

Technicals

About ALNY

Latest News

ALNY Stock Price, Quote & Chart | ALNYLAM PHARMACEUTICALS INC (NASDAQ:ALNY) - ChartMill

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A 49.88% Potential Upside for Biotech Investors - DirectorsTalk Interviews

Assessing Alnylam Pharmaceuticals (ALNY) Valuation After Mixed Share Performance And Strong AMVUTTRA Uptake - simplywall.st

Advanced Charts

Top Gainers

Top Losers